Norway· NO-ID_5C29AB76-BA00-44A5-9125-2133FB96839D
Hetronifly
A serplulimab product containing serplulimab, registered in Norway by Accord Healthcare S.L.U.. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Serplulimab is registered in 11 of 19 countries.
Countries holding a registration under ATC L01FF12 (serplulimab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Serplulimab · ATC L01FF12
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Serplulimab
- Manufacturer
- Accord Healthcare S.L.U.
- Country
- Norway (NO)
- ATC code
- L01FF12
- ATC class
- Serplulimab
- Defined daily dose
- 15 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_5C29AB76-BA00-44A5-9125-2133FB96839D
- no_varenummer43249010NOK 20664.4
- gtin5055565798072
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Serplulimab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumHetronifly 10 mg/mlAccord Healthcare
- SwitzerlandHetronifly 100 mg/10 ml, Konzentrat zur Herstellung einer InfusionslösungAccord Healthcare AG
- CzechiaHETRONIFLYAccord Healthcare S.L.U., Barcelona
- FinlandHETRONIFLYAccord Healthcare S.L.U.
- IrelandHETRONIFLY 10 mg/ml concentrate for solution for infusionAccord Healthcare S.L.U.
- IcelandHETRONIFLYAccord Healthcare S.L.U.
- PolandHetroniflyAccord Healthcare S.L.U.
- SwedenHETRONIFLY 10 mg/ml Koncentrat till infusionsvätska, lösningAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Hetronifly
- Iceland · Hetronifly
- Liechtenstein · Hetronifly
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e80e0267-0dc7-4488-801a-7d02424a868a GET /v1/drugs/e80e0267-0dc7-4488-801a-7d02424a868a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Serplulimab",
"merkevare_id": "ID_5C29AB76-BA00-44A5-9125-2133FB96839D",
"name_form_strength": "Hetronifly kons til inf oppl 10 mg/ml",
"prescription_group": "C"
}See everything about serplulimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.